Norplant-associated major depression and panic disorder

Area of Science:

• Reproductive Health
• Psychiatry
• Pharmacology

Background:

• Norplant is a subdermal contraceptive implant releasing levonorgestrel, a synthetic progestin.
• While oral contraceptives are linked to psychiatric issues, Norplant's psychiatric effects were previously unreported.
• This study investigates potential psychiatric side effects of Norplant.

Observation:

• Two women, aged 18 and 29, developed major depression and panic disorder after Norplant insertion.
• Symptoms emerged 1-2 months post-insertion and worsened over a year.
• No prior psychiatric history was reported in these cases.

Findings:

• Norplant use was temporally associated with the onset and exacerbation of depression and anxiety symptoms.
• Removal of the Norplant system led to the resolution of psychiatric symptoms within one month.
• These cases suggest a potential link between Norplant and the development of psychiatric disorders.

Implications:

• Progestin-only contraceptives like Norplant may contribute to depression and panic disorder in susceptible individuals.
• Healthcare providers should inquire about Norplant use when evaluating new psychiatric symptoms in women.
• Informed consent regarding potential psychiatric risks is crucial for Norplant users.